Publisher
Springer Berlin Heidelberg
Reference59 articles.
1. Alchalby H, Badbaran A, Bock O et al (2010a) Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 45:1404–1407
2. Alchalby H, Badbaran A, Zabelina T et al (2010b) Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis. Blood 116:3572–3581
3. Bacigalupo A, Dominetto A, Pozzi S et al (2007) Allogeneic hematopoietic stem transplant for patients with idiopathic myelofibrosis using a reduced intensity thiotepa based conditioning regimen. Blood 110: Abstract no. 684
4. Bacigalupo A, Soraru M, Dominietto A et al (2010) Allogeneic hematopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant 45:458–463
5. Ballen K, Zhang M, Arora M, the Chronic Leukemia Working Committee of the Center for International Blood Marrow Transplant Research (2005) Outcome of bone marrow transplantation for myelofibrosis. Blood 106: Abstract no. 170